PIN DM: PINNACLE® DM RSA Study

Sponsor
DePuy Orthopaedics (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05357664
Collaborator
(none)
45
3
2
39.7
15
0.4

Study Details

Study Description

Brief Summary

The primary objective is to establish the mean superior cup migration of the PINNACLE® Dual Mobility Construct using model-based RSA over the first two years post-implantation. The primary endpoint is the mean vertical subsidence (Y translation, also known as superior cup migration) at 2 years as measured with RSA. Additionally, the data from this study will be compared to historical PINNACLE® data obtained in study DSJ_2018_02.

Condition or Disease Intervention/Treatment Phase
  • Device: Total Hip Arthroplasty
  • Device: Revision Total Hip Arthroplasty
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
45 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Multi-Center, Non-Controlled, Prospective Radiostereometric Analysis of the PINNACLE® Dual Mobility Construct
Anticipated Study Start Date :
Aug 30, 2022
Anticipated Primary Completion Date :
Sep 30, 2025
Anticipated Study Completion Date :
Dec 19, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Total Hip Arthroplasty

Pinnacle acetabular shells used with PINNACLE DM Metal liner and BIMENTUM ALTRX PE liner with DePuy metal or ceramic heads and DePuy femoral prostheses

Device: Total Hip Arthroplasty
Pinnacle acetabular shells used with PINNACLE DM Metal liner and BIMENTUM ALTRX PE liner with DePuy metal or ceramic heads and DePuy femoral prostheses
Other Names:
  • THA
  • Experimental: Revision Total Hip Arthroplasty

    Pinnacle acetabular shells used with Pinnacle DM Metal liner and BIMENTUM ALTRX PE liner with DePuy metal or ceramic heads and DePuy femoral prostheses

    Device: Revision Total Hip Arthroplasty
    Pinnacle acetabular shells used with Pinnacle DM Metal liner and BIMENTUM ALTRX PE liner with DePuy metal or ceramic heads and DePuy femoral prostheses
    Other Names:
  • RTHA
  • Outcome Measures

    Primary Outcome Measures

    1. Mean superior cup migration (subsidence) at 2 years [24 months]

      RSA measured mean superior cup migration (subsidence: Y translation in mm) at 2 years. This endpoint will be compared to historical Pinnacle data

    Secondary Outcome Measures

    1. RSA measured cup subsidence at 3 months [3 months]

      RSA measured subsidence (in mm) of the Pinnacle Acetabular Shell. This endpoint will be compared to historical Pinnacle data

    2. X-axis translation of acetabular shell at 3 months [3 months]

      RSA measured X-axis translation of acetabular shell in mm. This endpoint will be compared to historical Pinnacle data

    3. Z-axis translation of acetabular shell at 3 months [3 months]

      RSA measured Z-axis translation of acetabular shell in mm. This endpoint will be compared to historical Pinnacle data

    4. X-axis rotation of the acetabular shell at 3 months [3 months]

      RSA measured X-axis rotation of the acetabular shell measured in degrees. This endpoint will be compared to historical Pinnacle data

    5. Y-axis rotation of the acetabular shell at 3 months [3 months]

      RSA measured Y-axis rotation of the acetabular shell measured in degrees. This endpoint will be compared to historical Pinnacle data

    6. Z-axis rotation of the acetabular shell at 3 months [3 months]

      RSA measured Z-axis rotation of the acetabular shell measured in degrees. This endpoint will be compared to historical Pinnacle data

    7. Maximal total point motion of the acetabular shell at 3 months [3 months]

      RSA measured maximal total point motion of the acetabular shell in mm. This endpoint will be compared to historical Pinnacle data

    8. Harris Hip Score at 3 months [3 months]

      Functional and health status as measured with the Harris Hip Score. This is a validated scoring system of the hip that has a result range of 0-100; the higher the score, the better the patient outcome. This endpoint will be compared to historical Pinnacle data

    9. HOOS Jr. Score at 3 months [3 months]

      Functional and health status as measured with the HOOS Jr. score. This is a short version of the HOOS (hip disability and osteoarthritis outcome score) that has a result range of 0-100. A score of 0 indicates total hip disability and 100 indicates perfect hip health. This endpoint will be compared to historical Pinnacle data

    10. FJS-12 at 3 months [3 months]

      Functional and health status as measured with the Forgotten Joint Score (FJS-12). This is a validated score that assesses patient outcomes. The result range is 0-100 where a higher score mean a more favorable result. This endpoint will be compared to historical Pinnacle data

    11. RSA measured cup subsidence at 12 months [12 months]

      RSA measured subsidence (in mm) of the Pinnacle Acetabular Shell. This endpoint will be compared to historical Pinnacle data

    12. X-axis translation of acetabular shell at 12 months [12 months]

      RSA measured X-axis translation of acetabular shell in mm. This endpoint will be compared to historical Pinnacle data

    13. Z-axis translation of acetabular shell at 12 months [12 months]

      RSA measured Z-axis translation of acetabular shell in mm. This endpoint will be compared to historical Pinnacle data

    14. X-axis rotation of the acetabular shell at 12 months [12 months]

      RSA measured X-axis rotation of the acetabular shell measured in degrees. This endpoint will be compared to historical Pinnacle data

    15. Y-axis rotation of the acetabular shell at 12 months [12 months]

      RSA measured Y-axis rotation of the acetabular shell measured in degrees. This endpoint will be compared to historical Pinnacle data

    16. Z-axis rotation of the acetabular shell at 12 months [12 months]

      RSA measured Z-axis rotation of the acetabular shell measured in degrees. This endpoint will be compared to historical Pinnacle data

    17. Maximal total point motion of the acetabular shell at 12 months [12 months]

      RSA measured maximal total point motion of the acetabular shell in mm. This endpoint will be compared to historical Pinnacle data

    18. Harris Hip Score at 12 months [12 months]

      Functional and health status as measured with the Harris Hip Score. This is a validated scoring system of the hip that has a result range of 0-100; the higher the score, the better the patient outcome. This endpoint will be compared to historical Pinnacle data

    19. HOOS Jr. Score at 12 months [12 months]

      Functional and health status as measured with the HOOS Jr. score. This is a short version of the HOOS (hip disability and osteoarthritis outcome score) that has a result range of 0-100. A score of 0 indicates total hip disability and 100 indicates perfect hip health. This endpoint will be compared to historical Pinnacle data

    20. FJS-12 at 12 months [12 months]

      Functional and health status as measured with the Forgotten Joint Score (FJS-12). This is a validated score that assesses patient outcomes. The result range is 0-100 where a higher score mean a more favorable result. This endpoint will be compared to historical Pinnacle data

    21. RSA measured cup subsidence at 6 months [6 months]

      RSA measured subsidence (in mm) of the Pinnacle Acetabular Shell. This endpoint will be compared to historical Pinnacle data

    22. X-axis translation of acetabular shell at 6 months [6 months]

      RSA measured X-axis translation of acetabular shell in mm. This endpoint will be compared to historical Pinnacle data

    23. Z-axis translation of acetabular shell at 6 months [6 months]

      RSA measured Z-axis translation of acetabular shell in mm. This endpoint will be compared to historical Pinnacle data

    24. X-axis rotation of the acetabular shell at 6 months [6 months]

      RSA measured X-axis rotation of the acetabular shell measured in degrees. This endpoint will be compared to historical Pinnacle data

    25. Y-axis rotation of the acetabular shell at 6 months [6 months]

      RSA measured Y-axis rotation of the acetabular shell measured in degrees. This endpoint will be compared to historical Pinnacle data

    26. Z-axis rotation of the acetabular shell at 6 months [6 months]

      RSA measured Z-axis rotation of the acetabular shell measured in degrees. This endpoint will be compared to historical Pinnacle data

    27. Maximal total point motion of the acetabular shell at 6 months [6 months]

      RSA measured maximal total point motion of the acetabular shell in mm. This endpoint will be compared to historical Pinnacle data

    28. Harris Hip Score at 6 months [6 months]

      Functional and health status as measured with the Harris Hip Score. This is a validated scoring system of the hip that has a result range of 0-100; the higher the score, the better the patient outcome. This endpoint will be compared to historical Pinnacle data

    29. HOOS Jr. Score at 6 months [6 months]

      Functional and health status as measured with the HOOS Jr. score. This is a short version of the HOOS (hip disability and osteoarthritis outcome score) that has a result range of 0-100. A score of 0 indicates total hip disability and 100 indicates perfect hip health. This endpoint will be compared to historical Pinnacle data

    30. FJS-12 at 6 months [6 months]

      Functional and health status as measured with the Forgotten Joint Score (FJS-12). This is a validated score that assesses patient outcomes. The result range is 0-100 where a higher score mean a more favorable result. This endpoint will be compared to historical Pinnacle data

    31. RSA measured cup subsidence at 24 months [24 months]

      RSA measured subsidence (in mm) of the Pinnacle Acetabular Shell. This endpoint will be compared to historical Pinnacle data

    32. X-axis translation of acetabular shell at 24 months [24 months]

      RSA measured X-axis translation of acetabular shell in mm. This endpoint will be compared to historical Pinnacle data

    33. Z-axis translation of acetabular shell at 24 months [24 months]

      RSA measured Z-axis translation of acetabular shell in mm. This endpoint will be compared to historical Pinnacle data

    34. X-axis rotation of the acetabular shell at 24 months [24 months]

      RSA measured X-axis rotation of the acetabular shell measured in degrees. This endpoint will be compared to historical Pinnacle data

    35. Y-axis rotation of the acetabular shell at 24 months [24 months]

      RSA measured Y-axis rotation of the acetabular shell measured in degrees. This endpoint will be compared to historical Pinnacle data

    36. Z-axis rotation of the acetabular shell at 24 months [24 months]

      RSA measured Z-axis rotation of the acetabular shell measured in degrees. This endpoint will be compared to historical Pinnacle data

    37. Maximal total point motion of the acetabular shell at 24 months [24 months]

      RSA measured maximal total point motion of the acetabular shell in mm. This endpoint will be compared to historical Pinnacle data

    38. Harris Hip Score at 24 months [24 months]

      Functional and health status as measured with the Harris Hip Score. This is a validated scoring system of the hip that has a result range of 0-100; the higher the score, the better the patient outcome. This endpoint will be compared to historical Pinnacle data

    39. HOOS Jr. Score at 24 months [24 months]

      Functional and health status as measured with the HOOS Jr. score. This is a short version of the HOOS (hip disability and osteoarthritis outcome score) that has a result range of 0-100. A score of 0 indicates total hip disability and 100 indicates perfect hip health. This endpoint will be compared to historical Pinnacle data

    40. FJS-12 at 24 months [24 months]

      Functional and health status as measured with the Forgotten Joint Score (FJS-12). This is a validated score that assesses patient outcomes. The result range is 0-100 where a higher score mean a more favorable result. This endpoint will be compared to historical Pinnacle data

    41. Cup Positioning at 6 weeks [6 weeks]

      Linear head penetration as determined by examining the change in distance between the center of the femoral head and the center of the acetabular shell at the 6-week exam. This endpoint will be compared to historical Pinnacle data

    42. Cup Positioning at 12 months [12 months]

      Linear head penetration as determined by examining the change in distance between the center of the femoral head and the center of the acetabular shell between the 6-week exam and 12 months. This endpoint will be compared to historical Pinnacle data

    43. Cup Positioning at 24 months [24 months]

      Linear head penetration as determined by examining the change in distance between the center of the femoral head and the center of the acetabular shell between the 6-week exam and 24 months. This endpoint will be compared to historical Pinnacle data

    44. X-axis translation of acetabular shell at 6 weeks [6 weeks]

      RSA measured X-axis translation of acetabular shell in mm. This endpoint will be compared to historical Pinnacle data

    45. Z-axis translation of acetabular shell at 6 weeks [6 weeks]

      RSA measured Z-axis translation of acetabular shell in mm. This endpoint will be compared to historical Pinnacle data

    46. X-axis rotation of the acetabular shell at 6 weeks [6 weeks]

      RSA measured X-axis rotation of the acetabular shell measured in degrees. This endpoint will be compared to historical Pinnacle data

    47. Y-axis rotation of the acetabular shell at 6 weeks [6 weeks]

      RSA measured Y-axis rotation of the acetabular shell measured in degrees. This endpoint will be compared to historical Pinnacle data

    48. Z-axis rotation of the acetabular shell at 6 weeks [6 weeks]

      RSA measured Z-axis rotation of the acetabular shell measured in degrees. This endpoint will be compared to historical Pinnacle data

    49. Maximal total point motion of the acetabular shell at 6 weeks [6 weeks]

      RSA measured maximal total point motion of the acetabular shell in mm. This endpoint will be compared to historical Pinnacle data

    50. Harris Hip Score at 6 weeks [6 weeks]

      Functional and health status as measured with the Harris Hip Score. This is a validated scoring system of the hip that has a result range of 0-100; the higher the score, the better the patient outcome. This endpoint will be compared to historical Pinnacle data

    51. HOOS Jr. Score at 6 weeks [6 weeks]

      Functional and health status as measured with the HOOS Jr. score. This is a short version of the HOOS (hip disability and osteoarthritis outcome score) that has a result range of 0-100. A score of 0 indicates total hip disability and 100 indicates perfect hip health. This endpoint will be compared to historical Pinnacle data

    52. FJS-12 at 6 weeks [6 weeks]

      Functional and health status as measured with the Forgotten Joint Score (FJS-12). This is a validated score that assesses patient outcomes. The result range is 0-100 where a higher score mean a more favorable result. This endpoint will be compared to historical Pinnacle data

    Other Outcome Measures

    1. Acetabular cup subsidence with a prior to discharge baseline [24 months]

      Subsidence for subset of subjects where RSA data was obtained prior to discharge. This endpoint will be compared to historical Pinnacle data

    2. Correlation of functional and health status outcomes vs. RSA [24 months]

      Analyses to examine the correlation of functional and health status outcomes vs. RSA observations may be explored. This endpoint will be compared to historical Pinnacle data

    3. Mean change from baseline values of Harris Hip Score, HOOS Jr. and Forgotten Joint Score [24 months]

      Change from baseline values for the study functional and health scores will be calculated from baseline to 24 months

    4. Safety Analyses [24 months]

      The overall incidence of safety events including intraprosthetic dislocations, intraoperative complications and adverse events will be summarized

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Individuals requiring primary THA for:

    2. a severely painful and/or disabled joint (typically due to non-inflammatory degenerative joint disease).

    3. failed previous hip surgery.

    4. or dislocation risks.

    5. Individuals who are able to speak, read and comprehend the informed patient consent document and willing and able to provide informed patient consent for participation in the study and have authorized the transfer of his/her information to DePuy Synthes.

    6. Individuals who are willing and able to return for follow-up as specified by the study protocol.

    7. Individuals who are a minimum age of 21 years at the time of consent.

    8. Individuals who are willing and able to complete the Subject Hip Outcomes questionnaires as specified by the study protocol.

    Exclusion Criteria:
    1. Individuals have active local or systemic infection.

    2. Individuals who have loss of musculature, neuromuscular compromise or vascular deficiency in the affected limb rendering the procedure unjustified.

    3. Individuals with poor bone quality, such as osteoporosis, where in the surgeon's opinion, there could be considerable migration of the prosthesis or a significant chance of bone fracture and/or the lack of adequate bone to support the implant(s).

    4. Individuals with Charcot's or Paget's disease.

    5. Individuals who, in the judgement of the investigator, would not be a candidate for protocol allowable components to be used for their THA.

    6. Women who are pregnant or lactating.

    7. Individuals who have had a contralateral hip that was implanted less than 6 months prior to the time of consent into this study or individuals that expect to have a contralateral hip implanted in the 6 months following the time of consent into this study.

    8. Individuals that have amputations in either leg that would impact rehabilitation following surgery.

    9. Individuals who are bedridden per the Investigators determination

    10. Individuals that have participated in a clinical investigation with an investigational product (drug or device) in the last three months.

    11. Individuals currently involved in any personal injury litigation, medical-legal or worker's compensation claims.

    12. Individuals, in the opinion of the Investigator, who are drug or alcohol abusers or have a psychological disorder that could affect their ability to complete patient reported questionnaires or be compliant with follow-up requirements.

    13. Individuals diagnosed and taking prescription medications to treat a muscular disorder that limits mobility due to sever stiffness and pain such as fibromyalgia or polymyalgia.

    14. Subject has a medical condition with less than 2 years life expectancy.

    15. Individual has a BMI >45 kg/m2.

    16. Individuals who require revision arthroplasty and have a well-fixed non-DePuy Synthes femoral stem or a well-fixed DePuy Synthes femoral stem that does not have a polished neck

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Concordia Joint Replacement Group, Concordia Hip and Knee Institute & University of Manitoba Winnipeg Manitoba Canada
    2 QEII Health Sciences Centre & Dalhousie University Halifax Nova Scotia Canada
    3 London Health Sciences Centre London Ontario Canada

    Sponsors and Collaborators

    • DePuy Orthopaedics

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    DePuy Orthopaedics
    ClinicalTrials.gov Identifier:
    NCT05357664
    Other Study ID Numbers:
    • DSJ_2019_02
    First Posted:
    May 3, 2022
    Last Update Posted:
    Aug 9, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    Yes
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 9, 2022